- Home
- NRIM vs SOPH Comparison
NRIM vs SOPH Comparison
Compare NRIM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIM | SOPH |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.4M | 330.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NRIM | SOPH |
|---|---|---|
| Price | $27.28 | $4.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 146.2K | 101.2K |
| Earning Date | 01-23-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | ★ 91.08 | N/A |
| EPS | ★ 2.80 | N/A |
| Revenue | ★ $201,544,000.00 | $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | $10.55 | $15.61 |
| P/E Ratio | $9.89 | ★ N/A |
| Revenue Growth | ★ 42.34 | 13.66 |
| 52 Week Low | $16.18 | $2.58 |
| 52 Week High | $28.21 | $5.30 |
Technical Indicators
Market Signals| Indicator | NRIM | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 58.02 | 49.43 |
| Support Level | $27.15 | $4.63 |
| Resistance Level | $28.21 | $4.95 |
| Average True Range (ATR) | 0.89 | 0.27 |
| MACD | 0.34 | -0.03 |
| Stochastic Oscillator | 72.15 | 15.13 |
Price Performance
Historical ComparisonAbout NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.